PharmaTelevision - Linda Chao of Stanford University Office of Technology Licensing talks about the LES Foundation Graduate Student Business Plan Competition

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Linda Chao of Stanford University Office of Technology Licensing talks about the LES Foundation Graduate Student Business Plan Competition

Visitors: You are watching a 5 minute preview.

Get more information and subscribe now

RSS

Twitter

In This Episode:

Summary
Transcript
Participants
Company

In this episode of PharmaTelevision News Review, Fintan Walton talks to Linda Chao, Senior Licensing Associate at Stanford University Office of Technology Licensing about the LES Foundation Competition.

Each year the LES Foundation, along with Licensing Executives Society (U.S.A. and Canada) and LES International invites graduate students from around the globe to participate in its International Graduate Student Business Plan Competition. The event uniquely focuses on business plans that emphasize intellectual property (IP) assets and strategies for how these assets will be leveraged to achieve business goals. For more information visit www.lesfoundation.org

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Graduate Business Plan Award

Fintan Walton:

Hello and welcome to PharmaTelevision News Review here at the LESI Conference in London, in 2011. On this show I have Linda Chao, who is Senior Associate at Stanford University's Office of Technology Licensing (OTL), welcome to the show.

Linda Chao:

Thank you, happy to be here.

Fintan Walton:

Linda, you have played a very important role in the Licensing Executive Society Foundation business plan award which is a graduate business plan award as I understand it, could you tell us first of all how you got involved in this particular award?

Linda Chao:

Okay, just to go back a little bit in history I've actually been involved with LES for about 14-years now. I've been at Stanford for 14-years and so I started off just going to the networking and education events, and about eight-years ago I volunteer to participate in this event where it was the first year they had a business plan competition I am involved with entrepreneurial activities that Stanford and I thought this will be a great program, so I started first half as just helping out being a judge and then more recently in the last four-years I've been in the chair of the competition and this is the first year we've had the finals outside of North America.

Fintan Walton:

Okay, very good. So tell us now a little bit about this graduate business plan award?

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Fintan Walton

Dr Fintan Walton is the Founder and CEO of PharmaVentures . After completing his doctoral research on the genetics of cell proliferation at the University of Michigan(US)and Trinity College (Dublin, Ireland), Dr Walton gained broad commercial experience in biotechnology in management positions at Bass and Celltech plc (1982-1992).

Linda Chao

Senior Associate

Linda Chao currently serves as Senior Licensing Associate at Stanford University's Office of Technology Licensing . Linda Chao holds B.S. Electrical Engineering (M.I.T), M.S. Electrical Engineering (M.I.T) and M.B.A. (M.I.T). Her previous work experiences include Digital Equipment Corporation (VLSI design) SEMATECH (competitive analysis of semiconductor industry) and Applied Materials (product marketing). Linda is an LES Foundation Board Member and Chair of the 2011 International Graduate Student Business Plan Competition.

PharmaVentures

PharmaVentures is a corporate finance and transactions advisory firm that has served hundreds of clients worldwide in relation to their strategic deal making in the pharmaceutical, life science and healthcare sectors. Our key offerings include: Transactions / deal negotiations; Product / technology valuations; Deal term advice; Due diligence & expert reports; Strategy formulation; Alliance management; and Expert opinion for litigation/arbitration cases. PharmaVentures provides the global expertise to ensure our clients generate the highest possible return on investment from all their deal making activities. We have experience of all therapeutic areas and can offer advice on both product and technology commercialisation.

The Licensing Executives Society (U.S.A. and Canada) Inc., LES International and the LES Foundation

The Licensing Executives Society, (U.S.A. and Canada) Inc. is the pre-eminent professional organization in the field of IP transfer and commercialization in the U.S.A. and Canada. It is one of over 30 member societies of the Licensing Executives Society International (LESI), which has over 12,000 members in 80 countries worldwide. The LES Foundation was established by the Licensing Executives Society, (U.S.A. and Canada), Inc., to increase awareness and understanding of the licensing of intellectual property rights and to communicate the critical role licensing plays in bringing creativity and innovation to the commercial marketplace.